ES2530175T3 - Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF - Google Patents
Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF Download PDFInfo
- Publication number
- ES2530175T3 ES2530175T3 ES12707193.4T ES12707193T ES2530175T3 ES 2530175 T3 ES2530175 T3 ES 2530175T3 ES 12707193 T ES12707193 T ES 12707193T ES 2530175 T3 ES2530175 T3 ES 2530175T3
- Authority
- ES
- Spain
- Prior art keywords
- tnf
- sample
- labeled
- drug
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940079593 drug Drugs 0.000 title abstract description 19
- 239000003814 drug Substances 0.000 title abstract description 19
- 238000001514 detection method Methods 0.000 title description 6
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 abstract description 24
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract description 24
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 abstract description 24
- 238000000034 method Methods 0.000 abstract description 13
- 239000002253 acid Substances 0.000 abstract description 4
- 238000001542 size-exclusion chromatography Methods 0.000 abstract description 4
- 230000003472 neutralizing effect Effects 0.000 abstract description 2
- 238000010494 dissociation reaction Methods 0.000 abstract 1
- 230000005593 dissociations Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 10
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 108700028353 OmpC Proteins 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 229920001184 polypeptide Polymers 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 150000001413 amino acids Chemical group 0.000 description 7
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 239000003550 marker Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 101000852992 Homo sapiens Interleukin-12 subunit beta Proteins 0.000 description 5
- 102100036701 Interleukin-12 subunit beta Human genes 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 229960000598 infliximab Drugs 0.000 description 5
- 229940116176 remicade Drugs 0.000 description 5
- 101001125026 Homo sapiens Nucleotide-binding oligomerization domain-containing protein 2 Proteins 0.000 description 4
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 4
- 101150111724 MEP1 gene Proteins 0.000 description 4
- 102100029441 Nucleotide-binding oligomerization domain-containing protein 2 Human genes 0.000 description 4
- 102100024333 Toll-like receptor 2 Human genes 0.000 description 4
- 230000009266 disease activity Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 102100031758 Extracellular matrix protein 1 Human genes 0.000 description 3
- 230000005526 G1 to G0 transition Effects 0.000 description 3
- 101000866526 Homo sapiens Extracellular matrix protein 1 Proteins 0.000 description 3
- 101001066435 Homo sapiens Hepatocyte growth factor-like protein Proteins 0.000 description 3
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 3
- 101000853000 Homo sapiens Interleukin-26 Proteins 0.000 description 3
- 101000578932 Homo sapiens Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 Proteins 0.000 description 3
- 101000586232 Homo sapiens ORM1-like protein 3 Proteins 0.000 description 3
- 101001117509 Homo sapiens Prostaglandin E2 receptor EP4 subtype Proteins 0.000 description 3
- 101000880431 Homo sapiens Serine/threonine-protein kinase 4 Proteins 0.000 description 3
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 3
- 101000597785 Homo sapiens Tumor necrosis factor receptor superfamily member 6B Proteins 0.000 description 3
- 102100037850 Interferon gamma Human genes 0.000 description 3
- 102100036679 Interleukin-26 Human genes 0.000 description 3
- 102100028328 Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 Human genes 0.000 description 3
- 102100030120 ORM1-like protein 3 Human genes 0.000 description 3
- 102100024450 Prostaglandin E2 receptor EP4 subtype Human genes 0.000 description 3
- 102100037629 Serine/threonine-protein kinase 4 Human genes 0.000 description 3
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 3
- 102100024587 Tumor necrosis factor ligand superfamily member 15 Human genes 0.000 description 3
- 108090000138 Tumor necrosis factor ligand superfamily member 15 Proteins 0.000 description 3
- 102100035284 Tumor necrosis factor receptor superfamily member 6B Human genes 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 208000001234 inflammatory bowel disease 5 Diseases 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 2
- 102100032366 C-C motif chemokine 7 Human genes 0.000 description 2
- 241000193469 Clostridium pasteurianum Species 0.000 description 2
- 102100040324 E3 ubiquitin-protein ligase RNF186 Human genes 0.000 description 2
- 102220583772 Extracellular matrix protein 1_T130M_mutation Human genes 0.000 description 2
- 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 description 2
- 101001104289 Homo sapiens E3 ubiquitin-protein ligase RNF186 Proteins 0.000 description 2
- 101000893424 Homo sapiens Glucokinase regulatory protein Proteins 0.000 description 2
- 101001050473 Homo sapiens Intelectin-1 Proteins 0.000 description 2
- 101001019615 Homo sapiens Interleukin-18 receptor accessory protein Proteins 0.000 description 2
- 101000960946 Homo sapiens Interleukin-19 Proteins 0.000 description 2
- 101000853012 Homo sapiens Interleukin-23 receptor Proteins 0.000 description 2
- 101001005528 Homo sapiens LYR motif-containing protein 4 Proteins 0.000 description 2
- 101001059982 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 5 Proteins 0.000 description 2
- 101001133059 Homo sapiens Mucin-19 Proteins 0.000 description 2
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 2
- 102000026659 IL10 Human genes 0.000 description 2
- 102100023353 Intelectin-1 Human genes 0.000 description 2
- 108090000174 Interleukin-10 Proteins 0.000 description 2
- 102100035010 Interleukin-18 receptor accessory protein Human genes 0.000 description 2
- 102100039879 Interleukin-19 Human genes 0.000 description 2
- 102100036672 Interleukin-23 receptor Human genes 0.000 description 2
- 102100025154 LYR motif-containing protein 4 Human genes 0.000 description 2
- 108010020246 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Proteins 0.000 description 2
- 102100032693 Leucine-rich repeat serine/threonine-protein kinase 2 Human genes 0.000 description 2
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 2
- 102100028195 Mitogen-activated protein kinase kinase kinase kinase 5 Human genes 0.000 description 2
- 102100034257 Mucin-19 Human genes 0.000 description 2
- 108010013381 Porins Proteins 0.000 description 2
- 108091006766 SLC22A23 Proteins 0.000 description 2
- 102100023100 Solute carrier family 22 member 23 Human genes 0.000 description 2
- 238000012896 Statistical algorithm Methods 0.000 description 2
- 108010016200 Zinc Finger Protein GLI1 Proteins 0.000 description 2
- 102100035535 Zinc finger protein GLI1 Human genes 0.000 description 2
- 102220485438 Zinc finger protein GLI1_G933D_mutation Human genes 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229960001743 golimumab Drugs 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- 102000007739 porin activity proteins Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 102210021745 rs10045431 Human genes 0.000 description 2
- 102210011296 rs11190140 Human genes 0.000 description 2
- 102200050485 rs11209026 Human genes 0.000 description 2
- 102210007410 rs11465804 Human genes 0.000 description 2
- 102200146742 rs2066844 Human genes 0.000 description 2
- 102200146596 rs2066845 Human genes 0.000 description 2
- 102200132076 rs2241880 Human genes 0.000 description 2
- 102210007414 rs4263839 Human genes 0.000 description 2
- 102200098764 rs4986790 Human genes 0.000 description 2
- 102200098513 rs4986791 Human genes 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- BQIMPGFMMOZASS-CLZZGJSISA-N (6r,7r)-7-amino-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(CO)=C(C(O)=O)N2C(=O)[C@@H](N)[C@H]21 BQIMPGFMMOZASS-CLZZGJSISA-N 0.000 description 1
- RBCCQATUVPNPGQ-UHFFFAOYSA-N 4-hexadecylaniline Chemical compound CCCCCCCCCCCCCCCCC1=CC=C(N)C=C1 RBCCQATUVPNPGQ-UHFFFAOYSA-N 0.000 description 1
- 102100021636 Actin-related protein 2/3 complex subunit 2 Human genes 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 241000893512 Aquifex aeolicus Species 0.000 description 1
- 108010092776 Autophagy-Related Protein 5 Proteins 0.000 description 1
- 102000016614 Autophagy-Related Protein 5 Human genes 0.000 description 1
- 102100040355 Autophagy-related protein 16-1 Human genes 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100025429 Butyrophilin-like protein 2 Human genes 0.000 description 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
- 102100036302 C-C chemokine receptor type 6 Human genes 0.000 description 1
- 102100025465 Calpain-10 Human genes 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 102100033187 Centrosomal protein of 72 kDa Human genes 0.000 description 1
- 101710202346 Centrosomal protein of 72 kDa Proteins 0.000 description 1
- 102100030099 Chloride anion exchanger Human genes 0.000 description 1
- 102100039193 Cullin-2 Human genes 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102100037799 DNA-binding protein Ikaros Human genes 0.000 description 1
- 101100457345 Danio rerio mapk14a gene Proteins 0.000 description 1
- 101100457347 Danio rerio mapk14b gene Proteins 0.000 description 1
- 102100022258 Disks large homolog 5 Human genes 0.000 description 1
- 102100023401 Dual specificity mitogen-activated protein kinase kinase 6 Human genes 0.000 description 1
- 102100039577 ETS translocation variant 5 Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010008165 Etanercept Proteins 0.000 description 1
- 108010040721 Flagellin Proteins 0.000 description 1
- 102100036242 HLA class II histocompatibility antigen, DQ alpha 2 chain Human genes 0.000 description 1
- 102100040485 HLA class II histocompatibility antigen, DRB1 beta chain Human genes 0.000 description 1
- 108010086786 HLA-DQA1 antigen Proteins 0.000 description 1
- 108010039343 HLA-DRB1 Chains Proteins 0.000 description 1
- 101000754220 Homo sapiens Actin-related protein 2/3 complex subunit 2 Proteins 0.000 description 1
- 101000964092 Homo sapiens Autophagy-related protein 16-1 Proteins 0.000 description 1
- 101000934738 Homo sapiens Butyrophilin-like protein 2 Proteins 0.000 description 1
- 101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 description 1
- 101000984149 Homo sapiens Calpain-10 Proteins 0.000 description 1
- 101000746072 Homo sapiens Cullin-2 Proteins 0.000 description 1
- 101000599038 Homo sapiens DNA-binding protein Ikaros Proteins 0.000 description 1
- 101000902114 Homo sapiens Disks large homolog 5 Proteins 0.000 description 1
- 101000624426 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 6 Proteins 0.000 description 1
- 101000813745 Homo sapiens ETS translocation variant 5 Proteins 0.000 description 1
- 101001003142 Homo sapiens Interleukin-12 receptor subunit beta-1 Proteins 0.000 description 1
- 101001003138 Homo sapiens Interleukin-12 receptor subunit beta-2 Proteins 0.000 description 1
- 101001010600 Homo sapiens Interleukin-12 subunit alpha Proteins 0.000 description 1
- 101000961065 Homo sapiens Interleukin-18 receptor 1 Proteins 0.000 description 1
- 101000971638 Homo sapiens Kinesin-like protein KIF1A Proteins 0.000 description 1
- 101001027634 Homo sapiens Kinesin-like protein KIF21B Proteins 0.000 description 1
- 101001008568 Homo sapiens Laminin subunit beta-1 Proteins 0.000 description 1
- 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 description 1
- 101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 description 1
- 101001080401 Homo sapiens Proteasome assembly chaperone 1 Proteins 0.000 description 1
- 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 1
- 101000738413 Homo sapiens T-cell surface glycoprotein CD3 gamma chain Proteins 0.000 description 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 1
- 101000666295 Homo sapiens X-box-binding protein 1 Proteins 0.000 description 1
- 101000919269 Homo sapiens cAMP-responsive element modulator Proteins 0.000 description 1
- 101000747206 Homo sapiens tRNA pseudouridine synthase Pus10 Proteins 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 102100020790 Interleukin-12 receptor subunit beta-1 Human genes 0.000 description 1
- 102100020792 Interleukin-12 receptor subunit beta-2 Human genes 0.000 description 1
- 102100030698 Interleukin-12 subunit alpha Human genes 0.000 description 1
- 102000003810 Interleukin-18 Human genes 0.000 description 1
- 108090000171 Interleukin-18 Proteins 0.000 description 1
- 102100039340 Interleukin-18 receptor 1 Human genes 0.000 description 1
- 102100021527 Kinesin-like protein KIF1A Human genes 0.000 description 1
- 102100037690 Kinesin-like protein KIF21B Human genes 0.000 description 1
- 102100027448 Laminin subunit beta-1 Human genes 0.000 description 1
- 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 1
- 108700012928 MAPK14 Proteins 0.000 description 1
- 101150003941 Mapk14 gene Proteins 0.000 description 1
- 102000054819 Mitogen-activated protein kinase 14 Human genes 0.000 description 1
- 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 101100454133 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) kstR2 gene Proteins 0.000 description 1
- 108091005461 Nucleic proteins Chemical group 0.000 description 1
- 101710203379 Outer membrane porin C Proteins 0.000 description 1
- 101710160101 Outer membrane protein C Proteins 0.000 description 1
- 102100027583 Proteasome assembly chaperone 1 Human genes 0.000 description 1
- 108091006504 SLC26A3 Proteins 0.000 description 1
- 102000005886 STAT4 Transcription Factor Human genes 0.000 description 1
- 108010019992 STAT4 Transcription Factor Proteins 0.000 description 1
- 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 1
- 102100037911 T-cell surface glycoprotein CD3 gamma chain Human genes 0.000 description 1
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 1
- 102220642274 Toll-like receptor 4_S400N_mutation Human genes 0.000 description 1
- 102100033117 Toll-like receptor 9 Human genes 0.000 description 1
- 108010047933 Tumor Necrosis Factor alpha-Induced Protein 3 Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 102100024596 Tumor necrosis factor alpha-induced protein 3 Human genes 0.000 description 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 1
- 102100038151 X-box-binding protein 1 Human genes 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229960002964 adalimumab Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 102100029387 cAMP-responsive element modulator Human genes 0.000 description 1
- 229960003115 certolizumab pegol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940090100 cimzia Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960000403 etanercept Drugs 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 102000057041 human TNF Human genes 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229960000856 protein c Drugs 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 102220090100 rs1045642 Human genes 0.000 description 1
- 102210007296 rs10883365 Human genes 0.000 description 1
- 102210008563 rs10889677 Human genes 0.000 description 1
- 102210007440 rs11805303 Human genes 0.000 description 1
- 102200012755 rs2032582 Human genes 0.000 description 1
- 102220001819 rs2066847 Human genes 0.000 description 1
- 102210011297 rs2201841 Human genes 0.000 description 1
- 102220147371 rs3212227 Human genes 0.000 description 1
- 102210007411 rs3828309 Human genes 0.000 description 1
- 102210033146 rs5743293 Human genes 0.000 description 1
- 102210021311 rs6478108 Human genes 0.000 description 1
- 102210011440 rs6478109 Human genes 0.000 description 1
- 102210009692 rs6556416 Human genes 0.000 description 1
- 102210021500 rs6584283 Human genes 0.000 description 1
- 102210007434 rs6887695 Human genes 0.000 description 1
- 102210019010 rs7517847 Human genes 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229940068638 simponi Drugs 0.000 description 1
- 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 1
- 238000012306 spectroscopic technique Methods 0.000 description 1
- 102100039155 tRNA pseudouridine synthase Pus10 Human genes 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 108091008023 transcriptional regulators Proteins 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161444097P | 2011-02-17 | 2011-02-17 | |
| US201161444097P | 2011-02-17 | ||
| US201161484594P | 2011-05-10 | 2011-05-10 | |
| US201161484594P | 2011-05-10 | ||
| US201161496501P | 2011-06-13 | 2011-06-13 | |
| US201161496501P | 2011-06-13 | ||
| PCT/US2012/025437 WO2012154253A1 (en) | 2011-02-17 | 2012-02-16 | ASSAYS FOR DETECTING AUTOANTIBODIES TO ANTI-TNFα DRUGS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2530175T3 true ES2530175T3 (es) | 2015-02-26 |
Family
ID=45809635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12707193.4T Active ES2530175T3 (es) | 2011-02-17 | 2012-02-16 | Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140045276A1 (enExample) |
| EP (1) | EP2676137B1 (enExample) |
| JP (1) | JP6063398B2 (enExample) |
| KR (1) | KR20140008397A (enExample) |
| CN (1) | CN103502815B (enExample) |
| AU (1) | AU2012254150B2 (enExample) |
| BR (1) | BR112013020981A2 (enExample) |
| CA (1) | CA2827609A1 (enExample) |
| DK (1) | DK2676137T3 (enExample) |
| ES (1) | ES2530175T3 (enExample) |
| IL (1) | IL227853A (enExample) |
| MX (1) | MX343327B (enExample) |
| RU (1) | RU2013142278A (enExample) |
| SG (1) | SG192770A1 (enExample) |
| WO (1) | WO2012154253A1 (enExample) |
| ZA (1) | ZA201306950B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12281359B2 (en) | 2013-05-17 | 2025-04-22 | Cedars-Sinai Medical Center | Variants of TNFSF15 and DCR3 associated with Crohn's disease |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110229471A1 (en) | 2008-11-26 | 2011-09-22 | Cedars-Sinai Medical Center | Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
| AU2010315547C1 (en) | 2009-10-26 | 2015-06-04 | Société des Produits Nestlé S.A. | Assays for the detection of anti-TNF drugs and autoantibodies |
| AU2011317149B2 (en) | 2010-10-18 | 2015-05-07 | Société des Produits Nestlé S.A. | Methods for determining anti-drug antibody isotypes |
| RU2013158256A (ru) | 2011-07-06 | 2015-07-10 | Нестек С.А. | АНАЛИЗЫ ДЛЯ ОБНАРУЖЕНИЯ НЕЙТРАЛИЗУЮЩИХ АУТОАНТИТЕЛ ДЛЯ БИОЛОГИЧЕСКОЙ ТЕРАПИИ TNFα |
| CN104718453B (zh) | 2012-10-03 | 2017-03-08 | Gyros专利公司 | 酸性条件下分析物测定用方法和试剂盒 |
| MX358730B (es) | 2012-10-05 | 2018-09-03 | Nestec Sa | Metodos para predecir y monitorear cicatrizacion de la mucosa. |
| BR112015012482A2 (pt) * | 2012-11-30 | 2017-07-11 | Nestec Sa | ensaios para detecção de autoanticorpos neutralizantes à terapia com produtos biológicos |
| WO2014122600A1 (en) | 2013-02-05 | 2014-08-14 | Nestec S.A. | Methods of selecting combination therapy for colorectal cancer patients |
| EP3639841B1 (en) | 2013-03-27 | 2023-09-06 | Cedars-Sinai Medical Center | Treating fibrosis by inhibiting tl1a |
| EP3022295A4 (en) | 2013-07-19 | 2017-03-01 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
| EP3654037A1 (en) | 2013-12-03 | 2020-05-20 | Prometheus Biosciences, Inc. | Methods for predicting post-operative recurrence of crohn's disease |
| WO2015110989A1 (en) | 2014-01-23 | 2015-07-30 | Nestec S.A. | Biomarker panel for assessment of mucosal healing |
| SG11201606291VA (en) | 2014-02-11 | 2016-08-30 | Genzyme Corp | Assays for detecting the presence or amount of an anti-drug antibody |
| US10267806B2 (en) | 2014-04-04 | 2019-04-23 | Mayo Foundation For Medical Education And Research | Isotyping immunoglobulins using accurate molecular mass |
| CN104034896A (zh) * | 2014-06-19 | 2014-09-10 | 华北制药集团新药研究开发有限责任公司 | 一种双抗体夹心elisa检测方法 |
| US10690676B2 (en) | 2014-07-29 | 2020-06-23 | Mayo Roundation for Medical Education and Research | Quantifying monoclonal antibody therapeutics by LC-MS/MS |
| WO2016063204A1 (en) * | 2014-10-20 | 2016-04-28 | Nestec S.A. | Methods for prediction of anti-tnf alpha drug levels and autoantibody formation |
| JP6739428B2 (ja) * | 2014-11-05 | 2020-08-12 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | エフェクター機能抑制型ヒトまたはヒト化薬物抗体に対する抗薬物抗体の決定方法 |
| ES2735085T3 (es) | 2014-12-05 | 2019-12-16 | Nestle Sa | Ensayos de cambio de movilidad homogéneos indirectos para la detección de agentes biológicos en muestras de pacientes |
| US11085931B2 (en) | 2015-01-09 | 2021-08-10 | W. Health L.P. | Universal assay for determining the quantity of TNFα inhibitory drugs and their corresponding anti-drug-antibodies |
| WO2016135707A1 (en) | 2015-02-27 | 2016-09-01 | Nestec S.A. | Diagnosis of major depressive disorder, mild cognitive impairment, and alzheimer's disease and other neurologic and psychiatric disorders |
| US11209439B2 (en) | 2015-09-24 | 2021-12-28 | Mayo Foundation For Medical Education And Research | Identification of immunoglobulin free light chains by mass spectrometry |
| ES2815224T3 (es) * | 2015-11-06 | 2021-03-29 | Promise Proteomics | Un método para cuantificar anticuerpos terapéuticos |
| JP7082945B2 (ja) | 2016-03-17 | 2022-06-09 | シーダーズ―シナイ メディカル センター | Ｒｎａｓｅｔ２により炎症性腸疾患を診断する方法 |
| EP3482199A1 (en) | 2016-07-08 | 2019-05-15 | Atonomics A/S | A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples |
| CN118443922A (zh) * | 2016-09-06 | 2024-08-06 | 富士瑞必欧株式会社 | 肿瘤标记物的测定方法及测定试剂 |
| US10955420B2 (en) | 2016-09-07 | 2021-03-23 | Mayo Foundation For Medical Education And Research | Identification and monitoring of cleaved immunoglobulins by molecular mass |
| US11946937B2 (en) | 2017-09-13 | 2024-04-02 | Mayo Foundation For Medical Education And Research | Identification and monitoring of apoptosis inhibitor of macrophage |
| US12153052B2 (en) | 2017-09-13 | 2024-11-26 | Mayo Foundation For Medical Education And Research | Identification and monitoring of immunoglobulin J chains |
| PL3717916T3 (pl) * | 2017-11-29 | 2025-04-07 | F. Hoffmann-La Roche Ag | Test do oznaczania przeciwciał przeciwlekowych z tłumieniem oddziaływania z cząsteczką docelową |
| ES3038185T3 (en) * | 2018-08-03 | 2025-10-10 | Bristol Myers Squibb Co | Methods for detecting anti-drug antibodies |
| EP3924352A4 (en) | 2019-02-11 | 2022-11-16 | Phoenix Molecular Designs | CRYSTALLINE FORMS OF AN RSK INHIBITOR |
| JP2020115139A (ja) * | 2020-03-11 | 2020-07-30 | 国立大学法人千葉大学 | 血管炎の検査方法 |
| KR102562006B1 (ko) | 2020-11-09 | 2023-08-02 | 바디텍메드(주) | 항tnf-알파 약물 모니터링을 위한 신속 검출 키트 |
| CN112362649B (zh) * | 2020-11-09 | 2024-07-12 | 长春金赛药业有限责任公司 | 一种rhGH中和抗体的检测方法 |
| KR102568430B1 (ko) * | 2020-11-16 | 2023-08-24 | 바디텍메드(주) | 항 약물 항체의 신속 검출 방법 |
| CN114236139A (zh) * | 2021-12-30 | 2022-03-25 | 苏州和锐生物科技有限公司 | 一种TNF-α生物制剂的抗体检测试剂盒、制备方法 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4459359A (en) * | 1981-11-19 | 1984-07-10 | New York Blood Center, Inc. | Sensitive immunoassays of antigens or antibodies sequestered within immune complexes |
| FR2590674B1 (fr) * | 1985-11-25 | 1989-03-03 | Inst Nat Sante Rech Med | Nouveaux reactifs de diagnostic |
| DE3631229A1 (de) | 1986-09-13 | 1988-03-24 | Basf Ag | Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung |
| US5094740A (en) * | 1990-02-16 | 1992-03-10 | Glycomed, Inc. | Two-dimensional electrophoretic separation of carbohydrates |
| GB9028123D0 (en) * | 1990-12-28 | 1991-02-13 | Erba Carlo Spa | Monoclonal antibodies against human tumor necrosis factor alpha |
| US6033864A (en) | 1996-04-12 | 2000-03-07 | The Regents Of The University Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens |
| US6074835A (en) | 1996-04-12 | 2000-06-13 | Regents Of The Univ. Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1 |
| US6406862B1 (en) | 1998-10-06 | 2002-06-18 | The United States Of America As Represented By The Secretary Of The Army | Dip-stick assay for C-reactive protein |
| JP2002538170A (ja) * | 1999-03-02 | 2002-11-12 | セントコール， インコーポレイテッド | 喘息の治療における抗−ＴＮＦα抗体 |
| US6309643B1 (en) | 1999-04-30 | 2001-10-30 | The Regents Of The University Of California | IBD-associated microbial antigens and methods of using same |
| FR2802536B1 (fr) | 1999-11-23 | 2003-06-13 | Chru Lille | Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections |
| FR2806739B1 (fr) | 2000-03-27 | 2005-02-18 | Fond Jean Dausset Ceph | Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation |
| US6838250B2 (en) | 2000-03-31 | 2005-01-04 | Ortho-Clinical Diagnostics, Inc. | Immunoassay for C-reactive protein |
| US7138237B1 (en) | 2000-05-19 | 2006-11-21 | Cedars-Sinai Medical Center | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
| DK1330525T3 (da) | 2000-10-30 | 2013-03-04 | Univ Michigan | NOD2-nukleinsyrer og proteiner |
| AU2002243415B2 (en) | 2000-10-30 | 2007-05-24 | Regents Of The University Of Michigan | Nod2 nucleic acids and proteins |
| AU2002902A (en) | 2000-11-14 | 2002-05-27 | Techlab Inc | Method for differentiating irritable bowel syndrome from inflammatory bowel disease (ibd) and for monitoring persons with ibd using total endogenous lactoferrinas a marker |
| DK1581119T3 (da) | 2001-12-17 | 2013-05-13 | Corixa Corp | Sammensætninger og fremgangsmåder til terapi og diagnose af inflammatoriske tarmsygdomme |
| US20040053263A1 (en) | 2002-08-30 | 2004-03-18 | Abreu Maria T. | Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease |
| WO2004037073A2 (en) | 2002-10-25 | 2004-05-06 | Techlab, Inc. | Inflammatory bowel disease and irritable bowel syndrome ibd-first chek diagnostic panel |
| US7662569B2 (en) | 2003-04-11 | 2010-02-16 | Cedars-Sinai Medical Center | Methods of assessing Crohn's disease patient phenotype by I2 serologic response |
| EP1687447A4 (en) | 2003-11-03 | 2008-04-02 | Univ Duke | METHOD FOR IDENTIFYING INDIVIDUALS IN THE HAZARD OF PERIOPERATIVE BLOODING, A KIDNEY PROBLEM OR A STROKE |
| CA2572263A1 (en) * | 2004-06-30 | 2006-01-12 | Centocor, Inc. | Detection or measurement of antibodies to antigenic proteins in biological tissues or samples |
| US20060019410A1 (en) | 2004-07-21 | 2006-01-26 | Qualyst, Inc. | Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation |
| JP2007147367A (ja) * | 2005-11-25 | 2007-06-14 | Sekisui Chem Co Ltd | サイトカイン産生能の測定方法 |
| US20110066624A1 (en) | 2006-08-01 | 2011-03-17 | Divyank Turakhia | system and method of generating related words and word concepts |
| WO2008036802A2 (en) | 2006-09-21 | 2008-03-27 | Prometheus Laboratories Inc. | Antibody-based arrays for detecting multiple signal transducers in rare circulating cells |
| WO2011008990A1 (en) | 2009-07-15 | 2011-01-20 | Prometheus Laboratories Inc. | Drug selection for gastric cancer therapy using antibody-based arrays |
| BRPI0813583A2 (pt) | 2007-07-13 | 2014-12-30 | Prometheus Lab Inc | Métodos para selecionar um medicamento anticâncer, para identificar a resposta de um tumor pulmonar, e para prognosticar a resposta de um paciente, e, arranjo |
| US20090035216A1 (en) * | 2007-08-03 | 2009-02-05 | Biomonitor Aps | Method for determining in vivo biopharmaceutical concentration or bioavailability |
| WO2009022001A1 (en) * | 2007-08-16 | 2009-02-19 | Novartis Ag | Improvement of drug tolerance in immunogenicity testing |
| US20110020840A1 (en) * | 2008-01-15 | 2011-01-27 | Gerrit Jan Wolbink | Method and kits for detecting antibodies against therapeutic antibodies |
| CN103399144B (zh) | 2008-02-25 | 2015-10-28 | 雀巢产品技术援助有限公司 | 用抗体阵列选择乳腺癌治疗药物 |
| WO2010042031A1 (en) * | 2008-10-07 | 2010-04-15 | Gyros Patent Ab | Semi-sequential assay for detection of an analyte in a sample |
| CA2761777A1 (en) | 2009-05-14 | 2010-11-18 | Prometheus Laboratories Inc. | Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy |
| US8408369B2 (en) | 2009-09-08 | 2013-04-02 | GM Global Technology Operations LLC | Bimetallic brake rotor |
| MX337666B (es) | 2009-10-20 | 2016-03-14 | Nestec Sa | Ensayos regulados mediante proximidad para detectar proteinas de fusion oncogenicas. |
| AU2010315547C1 (en) | 2009-10-26 | 2015-06-04 | Société des Produits Nestlé S.A. | Assays for the detection of anti-TNF drugs and autoantibodies |
-
2012
- 2012-02-16 ES ES12707193.4T patent/ES2530175T3/es active Active
- 2012-02-16 KR KR1020137024583A patent/KR20140008397A/ko not_active Ceased
- 2012-02-16 JP JP2013554602A patent/JP6063398B2/ja not_active Expired - Fee Related
- 2012-02-16 DK DK12707193.4T patent/DK2676137T3/en active
- 2012-02-16 BR BR112013020981A patent/BR112013020981A2/pt not_active Application Discontinuation
- 2012-02-16 SG SG2013061692A patent/SG192770A1/en unknown
- 2012-02-16 CA CA2827609A patent/CA2827609A1/en not_active Abandoned
- 2012-02-16 EP EP12707193.4A patent/EP2676137B1/en active Active
- 2012-02-16 CN CN201280018741.1A patent/CN103502815B/zh not_active Expired - Fee Related
- 2012-02-16 AU AU2012254150A patent/AU2012254150B2/en not_active Ceased
- 2012-02-16 MX MX2013009570A patent/MX343327B/es active IP Right Grant
- 2012-02-16 WO PCT/US2012/025437 patent/WO2012154253A1/en not_active Ceased
- 2012-02-16 RU RU2013142278/15A patent/RU2013142278A/ru not_active Application Discontinuation
-
2013
- 2013-08-07 US US13/961,841 patent/US20140045276A1/en not_active Abandoned
- 2013-09-03 IL IL227853A patent/IL227853A/en active IP Right Grant
- 2013-09-16 ZA ZA2013/06950A patent/ZA201306950B/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12281359B2 (en) | 2013-05-17 | 2025-04-22 | Cedars-Sinai Medical Center | Variants of TNFSF15 and DCR3 associated with Crohn's disease |
Also Published As
| Publication number | Publication date |
|---|---|
| IL227853A0 (en) | 2013-09-30 |
| AU2012254150B2 (en) | 2015-08-13 |
| KR20140008397A (ko) | 2014-01-21 |
| AU2012254150A1 (en) | 2013-05-02 |
| EP2676137A1 (en) | 2013-12-25 |
| RU2013142278A (ru) | 2015-03-27 |
| WO2012154253A1 (en) | 2012-11-15 |
| HK1191688A1 (en) | 2014-08-01 |
| DK2676137T3 (en) | 2015-01-19 |
| EP2676137B1 (en) | 2014-12-31 |
| ZA201306950B (en) | 2015-04-29 |
| SG192770A1 (en) | 2013-09-30 |
| NZ614170A (en) | 2015-04-24 |
| JP2014508930A (ja) | 2014-04-10 |
| CA2827609A1 (en) | 2012-11-15 |
| CN103502815B (zh) | 2015-09-23 |
| MX2013009570A (es) | 2013-09-06 |
| IL227853A (en) | 2017-07-31 |
| BR112013020981A2 (pt) | 2016-10-11 |
| JP6063398B2 (ja) | 2017-01-18 |
| MX343327B (es) | 2016-11-01 |
| CN103502815A (zh) | 2014-01-08 |
| US20140045276A1 (en) | 2014-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2530175T3 (es) | Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF | |
| US11160863B2 (en) | Methods of disease activity profiling for personalized therapy management | |
| CN103299190B (zh) | 确定抗药物抗体同种型的方法 | |
| AU2005314089B2 (en) | Methods for diagnosis and treatment of Crohn's disease | |
| AU2011202664B2 (en) | Methods for diagnosis and treatment of Crohn's disease | |
| US20230110385A1 (en) | Non-invasive detection of salivary autoantibodies | |
| Miyaji et al. | Complement regulatory proteins (CD46, 55 and 59) expressed on Schwann cells: Immune targets in demyelinating neuropathies? | |
| RU2146368C1 (ru) | Способ выявления возбудителя инфекционного процесса в стерильных биологических средах макроорганизма | |
| CN103748470A (zh) | 一种预测治疗神经发育、神经学或神经精神病学疾病的临床益处的方法 | |
| De Benedetti et al. | Structure, Immunoreactivity, and In Silico Epitope Determination of SmSPI S. mansoni Serpin for Immunodiagnostic Application. Vaccines 2021, 9, 322 | |
| Kumar et al. | Molecular mechanisms and risk factors in rheumatoid arthritis: a comprehensive review | |
| Horta | Novel biosensing concepts for advancing antigen-specific antibody detection | |
| Quraishi et al. | PTH-102 Association of gut microbiota with mucosal inflammation in ulcerative colitis | |
| van Slochteren et al. | P1406 Direct detection of bacterial DNA in clinical samples; evaluating a 4½ year period of sample collection and analysis | |
| NZ614170B2 (en) | Assays for detecting autoantibodies to anti-tnf? drugs | |
| HK1191688B (en) | ASSAYS FOR DETECTING AUTOANTIBODIES TO ANTI-TNFα DRUGS |